Status: Recruiting
Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
Evaluation of the Effect of metamizole (Optalgin®) on Anti-Xa Levels in Oncology Patients Receiving Direct Oral Anticoagulants (DOACs)
Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Rambam Health Care CampusUpdated: Feb 3, 2026Locations: 1
Eligibility criteria
Adult oncology patients (≥18 years old). [+5]
History of allergic reaction to metamizole or DOACs. [+1]